Optimize the combination regimen of Trastuzumab and Nab-paclitaxel in HER2-positive tumors via modulating Caveolin-1 expression by lovastatin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimize the combination regimen of Trastuzumab and Nab-paclitaxel in HER2-positive tumors via modulating Caveolin-1 expression by lovastatin

Published:2022-08 Issue:5 Volume:17 Page:697-712
ISSN:1818-0876
Container-title:Asian Journal of Pharmaceutical Sciences
language:en
Short-container-title:Asian Journal of Pharmaceutical Sciences

Author:

Yang Canyu,Fan Shumin,Wang Xing,Liu Wei,Yang Long^ORCID,He Bing,Dai Wenbing^ORCID,Zhang Hua,Wang Xueqing,Zhang Qiang

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference52 articles.

1. The basic biology of HER2;Rubin;Ann Oncol,2001

2. HER2-targeted therapies - a role beyond breast cancer;Oh;Nat Rev Clin Oncol,2020

3. HER2 expression status in diverse cancers: review of results from 37,992 patients;Yan;Cancer Metastasis Rev,2015

4. The role of overexpressed HER2 in transformation;Neve;Ann Oncol,2001

5. HER2-positive breast cancer;Engel;Drugs,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain‐Targeted Black Phosphorus‐Based Nanotherapeutic Platform for Enhanced Hypericin Delivery in Depression;Small;2024-03-10

2. Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer;Journal of Controlled Release;2024-01

3. Nano-formulated delivery of active ingredients from traditional Chinese herbal medicines for cancer immunotherapy;Acta Pharmaceutica Sinica B;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP